Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pharmaceutical company Bionovo has filed a preliminary prospectus supplement to an existing shelf registration statement with the Securities and Exchange Commission relating to a proposed public offering of 11.4 million shares of its common stock.
Subscribe to our email newsletter
Bionovo expects to grant its underwriters a 30-day option to purchase up to 1.71 million shares at the public offering price to cover over-allotments, if any.
BMO Capital Markets and Canaccord Adams are acting as joint book-running managers for the proposed offering, with Merriman Curhan Ford acting as a co-manager.